PMV PHARMACEUTICALS INC filings

SEC filings by PMV PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2023-02-09VANGUARD GROUP INCPMV Pharmaceuticals, Inc.2,753,6066.0%EDGAR
SC 13G/A2023-01-31BlackRock Inc.PMV Pharmaceuticals, Inc.3,451,3677.6%EDGAR
SC 13G/A2023-01-25JPMORGAN CHASE & COPMV Pharmaceuticals, Inc.4,004,7678.7%EDGAR
SC 13G/A2023-01-24Cowen Financial Products LLCPMV Pharmaceuticals, Inc.1,500,3263.3%EDGAR
SC 13G2022-07-11STATE STREET CORPPMV Pharmaceuticals, Inc.-11.4%EDGAR
SC 13G/A2022-07-07JPMORGAN CHASE & COPMV Pharmaceuticals, Inc.4,585,45910.0%EDGAR
SC 13G2022-06-17CITADEL ADVISORS LLCPMV Pharmaceuticals, Inc.-3.1%EDGAR
SC 13D/A2022-04-01ORBIMED ADVISORS LLCPMV Pharmaceuticals, Inc.6,589,33014.5%EDGAR
SC 13G/A2022-02-14Nextech V Oncology S.C.S., SICAV-SIFPMV Pharmaceuticals, Inc.1,385,8073.1%EDGAR
SC 13G/A2022-02-14VIKING GLOBAL INVESTORS LPPMV Pharmaceuticals, Inc.1,790,2843.9%EDGAR
SC 13G/A2022-02-14INTERWEST PARTNERS X LPPMV Pharmaceuticals, Inc.3,234,9117.1%EDGAR
SC 13G/A2022-02-14Euclidean Capital LLCPMV Pharmaceuticals, Inc.2,336,9095.1%EDGAR
SC 13G/A2022-02-14Boxer Capital, LLCPMV Pharmaceuticals, Inc.2,838,2366.3%EDGAR
SC 13G2022-02-14RTW INVESTMENTS, LPPMV Pharmaceuticals, Inc.2,980,9606.6%EDGAR
SC 13G/A2022-02-11Avoro Capital Advisors LLCPMV Pharmaceuticals, Inc.1,465,0003.2%EDGAR
SC 13G2022-02-10VANGUARD GROUP INCPMV Pharmaceuticals, Inc.2,647,9465.8%EDGAR
SC 13G2022-02-04BlackRock Inc.PMV Pharmaceuticals, Inc.2,539,8245.6%EDGAR
SC 13G2022-01-26JPMORGAN CHASE & COPMV Pharmaceuticals, Inc.3,166,4506.9%EDGAR
SC 13G2022-01-19Cowen Financial Products LLCPMV Pharmaceuticals, Inc.2,300,0005.1%EDGAR
SC 13G/A2021-10-18Euclidean Capital LLCPMV Pharmaceuticals, Inc.2,455,1995.4%EDGAR